adamantane has been researched along with adenosine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, S; Ishii, A; Nonaka, H; Ono, E; Shimada, J; Shiozaki, S; Suzuki, F | 1 |
| Honda, Z; Iizasa, T; Kamatani, N; Miyamoto, T; Nishida, Y; Takeuchi, F | 1 |
| Bianchi, V; Bonvini, P; Borella, S; Ferraro, P; Reichard, P | 1 |
| Cheng, DY; DeWitt, BJ; Kadowitz, PJ; Neely, CF; Suzuki, F | 1 |
| Castagliuolo, I; Matthews, JB; Pothoulakis, C; Riegler, M; Sogukoglu, T; Wang, C; Wenzl, E; Wlk, M | 1 |
| Galun, E; Matot, I; Rivo, J; Zeira, E | 1 |
| Boegehold, MA; Falck, JR; Marowsky, A; Morisseau, C; Nayeem, MA; Ponnoth, DS; Roush, KP; Zeldin, DC | 1 |
| Falck, JR; Morisseau, C; Mustafa, SJ; Nayeem, MA; Pradhan, I; Zeldin, DC | 1 |
| Warren, RB; Yiu, ZZ | 1 |
1 review(s) available for adamantane and adenosine
| Article | Year |
|---|---|
Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.
Topics: Adamantane; Adenosine; Adenosine A3 Receptor Antagonists; Administration, Oral; Arthritis, Psoriatic; Azetidines; Biological Factors; Biological Therapy; Clinical Trials as Topic; Humans; Isonicotinic Acids; Janus Kinases; Niacinamide; Phosphodiesterase 4 Inhibitors; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Receptors, Lysosphingolipid; rho-Associated Kinases; Sulfonamides; Thalidomide; Thiazoles | 2016 |
8 other study(ies) available for adamantane and adenosine
| Article | Year |
|---|---|
7,8-Dihydro-8-ethyl-2-(3-noradamantyl)-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-one: a potent and water-soluble adenosine A1 antagonist.
Topics: Adamantane; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Guinea Pigs; Hemodynamics; Imidazoles; Purinergic Antagonists; Purinones; Rats; Receptors, Purinergic; Solubility; Vasodilator Agents | 1992 |
Differential composition of cytosol 5'-nucleotidases between T and B lymphoblasts.
Topics: 5'-Nucleotidase; Adamantane; Adenosine; B-Lymphocytes; Cell Line; Chromatography; Chromatography, Gel; Cytosol; Deoxyadenosines; Humans; Hydrogen-Ion Concentration; Inosine Monophosphate; Nucleotidases; Substrate Specificity; T-Lymphocytes | 1986 |
Effects of mutational loss of nucleoside kinases on deoxyadenosine 5'-phosphate/deoxyadenosine substrate cycle in cultured CEM and V79 cells.
Topics: Adamantane; Adenine; Adenosine; Adenosine Kinase; Animals; Cell Division; Cell Line; Cricetinae; Deoxyadenosines; Deoxycytidine; Deoxycytidine Kinase; Deoxyribonucleotides; DNA; Fibroblasts; Humans; Hypoxanthine; Hypoxanthines; Kinetics; Lymphocytes; Thymidine; Time Factors; Tritium | 1994 |
Adenosine A1 and A2 receptors mediate tone-dependent responses in feline pulmonary vascular bed.
Topics: Adamantane; Adenosine; Adenosine Triphosphate; Animals; Arginine; Cats; Female; Male; Methylene Blue; Morpholines; Muscle Tonus; Muscle, Smooth, Vascular; Prostaglandin-Endoperoxide Synthases; Pulmonary Circulation; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Xanthines | 1996 |
Neurotensin stimulates Cl(-) secretion in human colonic mucosa In vitro: role of adenosine.
Topics: Adamantane; Adenosine; Adenosine Deaminase Inhibitors; Affinity Labels; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Chlorides; Colon; Electrophysiology; Enteric Nervous System; Enzyme Inhibitors; Guanosine; Histamine; Humans; Imidazoles; In Vitro Techniques; Indomethacin; Intestinal Mucosa; Mast Cells; Membrane Potentials; Neurotensin; Pentostatin; Pyrazoles; Quinolines; Receptors, Neurotensin; Tetrodotoxin; Thioinosine; Thionucleosides | 2000 |
Activation of A3 adenosine receptors attenuates lung injury after in vivo reperfusion.
Topics: Adamantane; Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; ATP-Binding Cassette Transporters; Cats; Dihydropyridines; Enzyme Inhibitors; Hemodynamics; Histamine; In Vitro Techniques; KATP Channels; Lung; Morpholines; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pulmonary Artery; Reperfusion Injury | 2004 |
Modulation by salt intake of the vascular response mediated through adenosine A(2A) receptor: role of CYP epoxygenase and soluble epoxide hydrolase.
Topics: Acetylcholine; Adamantane; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Amides; Animals; Arginine; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Decanoic Acids; Epoxide Hydrolases; Hydroxy Acids; Lauric Acids; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Phenethylamines; Sodium Chloride, Dietary; Vasoconstriction | 2010 |
Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARĪ³.
Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine-5'-(N-ethylcarboxamide); Animals; Benzamides; Benzoates; Butyrates; Enzyme Inhibitors; Epoxide Hydrolases; Female; Gene Silencing; Lauric Acids; Male; Mice; NG-Nitroarginine Methyl Ester; Oxygenases; Phenethylamines; Phenylurea Compounds; PPAR gamma; Pyridines; Pyrimidines; Receptor, Adenosine A2A; Triazines; Triazoles; Urea; Vasodilation; Vasodilator Agents | 2013 |